{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:04:16Z","timestamp":1790280256138,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T00:00:00Z","timestamp":1688428800000},"content-version":"am","delay-in-days":276,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["P30 AR072577"],"award-info":[{"award-number":["P30 AR072577"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R03 AR078938"],"award-info":[{"award-number":["R03 AR078938"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["K23 AR073334"],"award-info":[{"award-number":["K23 AR073334"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01 AR077607"],"award-info":[{"award-number":["R01 AR077607"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["P30 AR070253"],"award-info":[{"award-number":["P30 AR070253"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.semarthrit.2022.152059","type":"journal-article","created":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T20:43:09Z","timestamp":1656448989000},"page":"152059","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Risk of gout flares after COVID-19 vaccination: A case-crossover study"],"prefix":"10.1016","volume":"56","author":[{"given":"Hui","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Dalbeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary S","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A","family":"Sparks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongxing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghua","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2022.152059_bib0001","unstructured":"World Health Organization Coronavirus (COVID-19) Dashboard, https:\/\/covid19.who.int\/; 2022 [accessed 14 June 2022]."},{"issue":"10285","key":"10.1016\/j.semarthrit.2022.152059_bib0002","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/S0140-6736(21)00677-2","article-title":"Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study","volume":"397","author":"Vasileiou","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2022.152059_bib0003","doi-asserted-by":"crossref","first-page":"n1088","DOI":"10.1136\/bmj.n1088","article-title":"Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study","volume":"373","author":"Lopez Bernal","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.semarthrit.2022.152059_bib0004","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1477-7525-10-117","article-title":"Tophi and frequent gout flares are associated with impairments to quality of life, productivity, and increased healthcare resource use: results from a cross-sectional survey","volume":"10","author":"Khanna","year":"2012","journal-title":"Health Qual Life Outcomes"},{"issue":"22","key":"10.1016\/j.semarthrit.2022.152059_bib0005","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","article-title":"Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults","volume":"372","author":"Lal","year":"2015","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.semarthrit.2022.152059_bib0006","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1603800","article-title":"Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older","volume":"375","author":"Cunningham","year":"2016","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.semarthrit.2022.152059_bib0007","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1136\/annrheumdis-2019-215724","article-title":"Risk of gout flares after vaccination: a prospective case cross-over study","volume":"78","author":"Yokose","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2022.152059_bib0008","series-title":"Fdabiologics license application clinical review memorandum: shingrix","author":"Paula","year":"2017"},{"key":"10.1016\/j.semarthrit.2022.152059_bib0009","article-title":"Colchicine prophylaxis is associated with fewer gout flares after COVID-19 vaccination","author":"Lu","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2022.152059_bib0010","unstructured":"Vaccinations inUnited Kingdom, https:\/\/coronavirus.data.gov.uk\/details\/vaccinations; 2022 [accessed 14 June 2022]."},{"issue":"4","key":"10.1016\/j.semarthrit.2022.152059_bib0011","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1136\/annrheumdis-2013-204463","article-title":"Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study","volume":"74","author":"Kuo","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.semarthrit.2022.152059_bib0012","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/jama.2019.1347","article-title":"Association of tramadol with all-cause mortality among patients with osteoarthritis","volume":"321","author":"Zeng","year":"2019","journal-title":"JAMA"},{"issue":"9596","key":"10.1016\/j.semarthrit.2022.152059_bib0013","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2022.152059_bib0014","doi-asserted-by":"crossref","DOI":"10.7326\/M21-2347","article-title":"Allopurinol initiation and all-cause mortality among patients with gout and concurrent chronic kidney disease: a population-based cohort study","author":"Wei","year":"2022","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.semarthrit.2022.152059_bib0015","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.3899\/jrheum.170444","article-title":"Gout and the risk of incident erectile dysfunction: a body mass index-matched population-based study","volume":"45","author":"Schlesinger","year":"2018","journal-title":"J Rheumatol"},{"issue":"11","key":"10.1016\/j.semarthrit.2022.152059_bib0016","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1001\/jamainternmed.2018.4463","article-title":"Association of chronic kidney disease with allopurinol use in gout treatment","volume":"178","author":"Vargas-Santos","year":"2018","journal-title":"JAMA Intern Med"},{"issue":"12","key":"10.1016\/j.semarthrit.2022.152059_bib0017","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1002\/art.39330","article-title":"Sleep apnea and the risk of incident gout: a population-based, body mass index-matched cohort study","volume":"67","author":"Zhang","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2022.152059_bib0018","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1046\/j.1365-2125.1997.00647.x","article-title":"Omeprazole, other antiulcer drugs and newly diagnosed gout","volume":"44","author":"Meier","year":"1997","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.semarthrit.2022.152059_bib0019","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/00001648-200103000-00010","article-title":"Referent selection in case-crossover analyses of acute health effects of air pollution","volume":"12","author":"Levy","year":"2001","journal-title":"Epidemiology"},{"issue":"6","key":"10.1016\/j.semarthrit.2022.152059_bib0020","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/01.ede.0000181315.18836.9d","article-title":"Case-crossover analyses of air pollution exposure data: referent selection strategies and their implications for bias","volume":"16","author":"Janes","year":"2005","journal-title":"Epidemiology"},{"issue":"6","key":"10.1016\/j.semarthrit.2022.152059_bib0021","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/01.ede.0000183170.92955.25","article-title":"Optimal referent selection strategies in case-crossover studies: a settled issue","volume":"16","author":"Mittleman","year":"2005","journal-title":"Epidemiology"},{"issue":"5","key":"10.1016\/j.semarthrit.2022.152059_bib0022","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/rheumatology\/keq363","article-title":"Frequency and risk factors of gout flares in a large population-based cohort of incident gout","volume":"50","author":"Rothenbacher","year":"2011","journal-title":"Rheumatology (Oxford)"},{"issue":"7198","key":"10.1016\/j.semarthrit.2022.152059_bib0023","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/nature06939","article-title":"Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants","volume":"453","author":"Eisenbarth","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.semarthrit.2022.152059_bib0024","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.coi.2019.02.009","article-title":"Understanding the immunology of Shingrix, a recombinant glycoprotein E adjuvanted herpes zoster vaccine","volume":"59","author":"Heineman","year":"2019","journal-title":"Curr Opin Immunol"},{"issue":"22","key":"10.1016\/j.semarthrit.2022.152059_bib0025","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2022.152059_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102662","article-title":"Mechanisms of immunothrombosis in vaccine-induced thrombotic thrombocytopenia (VITT) compared to natural SARS-CoV-2 infection","volume":"121","author":"McGonagle","year":"2021","journal-title":"J Autoimmun"},{"key":"10.1016\/j.semarthrit.2022.152059_bib0027","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.779453","article-title":"Inflammation and platelet activation after COVID-19 vaccines - possible mechanisms behind vaccine-induced immune thrombocytopenia and thrombosis","volume":"12","author":"Ostrowski","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.semarthrit.2022.152059_bib0028","article-title":"Effects of short-term corticosteroid use on reactogenicity and immunogenicity of the first dose of ChAdOx1 nCoV-19 vaccine","volume":"12","author":"Yang","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.semarthrit.2022.152059_bib0029","article-title":"Interdependencies of cellular and humoral immune responses in heterologous and homologous SARS-CoV-2 vaccination","author":"Hollstein","year":"2022","journal-title":"Allergy"},{"issue":"11","key":"10.1016\/j.semarthrit.2022.152059_bib0030","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/aje\/kwx105","article-title":"The case-crossover design: a method for studying transient effects on the risk of acute events","volume":"185","year":"2017","journal-title":"Am J Epidemiol"},{"issue":"3","key":"10.1016\/j.semarthrit.2022.152059_bib0031","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.semarthrit.2015.06.013","article-title":"Colchicine\u2013Update on mechanisms of action and therapeutic uses","volume":"45","author":"Leung","year":"2015","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.semarthrit.2022.152059_bib0032","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/art.41247","article-title":"2020 American college of rheumatology guideline for the management of gout","volume":"72","author":"FitzGerald","year":"2020","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"10.1016\/j.semarthrit.2022.152059_bib0033","doi-asserted-by":"crossref","DOI":"10.3390\/jpm11090935","article-title":"Colchicine use and risks of stroke recurrence in acute non-cardiogenic ischemic stroke patients: a population-based cohort study","volume":"11","author":"Liu","year":"2021","journal-title":"J Pers Med"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004901722200110X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004901722200110X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:50:33Z","timestamp":1790279433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004901722200110X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":33,"alternative-id":["S004901722200110X"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2022.152059","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of gout flares after COVID-19 vaccination: A case-crossover study","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2022.152059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152059"}}